The p53 activator overcomes resistance to ALK inhibitors sorted by
relevance

Admin26.07.2021

The p53 activator overcomes resistance to ALK inhibitors

9702
Admin15.07.2021

The p53 activator overcomes resistance to ALK inhibitors

3709
Admin06.08.2021

(PDF) The p53 activator overcomes resistance to ALK

Admin29.08.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

9708
Admin11.09.2021

The p53 activator overcomes resistance to ALK inhibitors

7209
Admin23.09.2021

The p53 activator overcomes resistance to ALK inhibitors

3309
Admin27.08.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

206
Admin06.10.2021

Combination of ALK inhibitor and p53 activator effectively

3505
Admin17.08.2021

p53 Activation by RG Abrogates Inherent Resistance to Bcl

6900
Admin14.09.2021

Activation of the p53 response upon co-treatment with

1205
Admin16.07.2021

Bcl-2 Inhibition Reciprocally Overcomes Resistance to p53

6504
Admin29.09.2021

美国APExBIO中文官网 - RG7112|MDM2 inhibitor, first clinical|CAS

6903
Admin13.08.2021

美国APExBIO中文官网 - RG7112|MDM2 inhibitor, first clinical|CAS

Admin16.09.2021

| TRIB2-mediated resistance to chemotherapeutics is via

8405
Admin28.09.2021

p53 Activator RG Overcomes the Resistance of AML Cells

705
Admin10.09.2021

(PDF) Lenvatinib in combination with golvatinib overcomes

9703
Admin08.10.2021

Multiple receptor tyrosine kinase activation related to

3200
Admin07.10.2021

Activation of the p53 pathway by the MDM2 inhibitor nutlin

4209
Admin27.08.2021

ALK inhibitors elicit cell-cycle arrest, but not cell

Admin01.08.2021

(PDF) PAK signalling drives acquired drug resistance to

Admin23.09.2021

(PDF) Mutant p53 improves cancer cells resistance to

7402